We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAnti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on AdalimumabAuthorsArmuzzi, A.; Lionetti, P.; Blandizzi, C.; Caporali, R.; Chimenti, S.; Cimino, L.; Gionchetti, P.; Girolomoni, G.; Lapadula, G.; Marchesoni, A.; Marcellusi, A.; Mennini, F.S.; Salvarani, C.; Cimaz, R.PublicationInternational Journal of Immunopathology and Pharmacology, 2014, Vol 27, Issue Supplement, p11ISSN0394-6320Publication typearticleDOI10.1177/03946320140270S102